Vox Sanguinis

Papers
(The median citation count of Vox Sanguinis is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group110
Impact of the COVID‐19 pandemic on blood supply and demand in the WHO African Region42
Neonatal red blood cell transfusion33
Blood donation in times of crisis: Early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries32
The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusion30
Research initiatives of blood services worldwide in response to the covid‐19 pandemic26
COVID‐19 convalescent plasma therapy: hit fast, hit hard!24
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic23
ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population20
Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices19
Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)‐positive blood products to Rh(D)‐negative children18
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma18
Motivation, blood donor satisfaction and intention to return during the COVID‐19 pandemic18
Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: A meta‐analysis of randomized controlled trials18
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary16
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems16
Estimating the risks of prehospital transfusion of D‐positive whole blood to trauma patients who are bleeding in England15
Blood donation by men who have sex with men: using evidence to change policy14
A pilot randomized clinical trial of cryopreserved versus liquid‐stored platelet transfusion for bleeding in cardiac surgery: The cryopreserved versus liquid plateletNew Zealand pilot tria14
Exchange transfusions in severe Rh‐mediated alloimmune haemolytic disease of the foetus and newborn: a 20‐year overview on the incidence, associated risks and outcome13
Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma12
Incidence of anti‐D alloimmunization in D‐negative individuals receiving D‐positive red blood cell transfusion: A systematic review and meta‐analysis12
Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance12
Assessing the inactivation capabilities of two commercially available platelet component pathogen inactivation systems: effectiveness at end of shelf life11
Activity‐based cost of platelet transfusions in medical and surgical inpatients at a US hospital11
Clinical consequences of the extremely rare anti‐PP1Pk isoantibodies in pregnancy: a case series and review of the literature10
Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop10
Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic9
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?9
Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulati9
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology9
Impact of disasters on blood donation rates and blood safety: A systematic review and meta‐analysis9
Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study9
Anti‐A and SARS‐CoV‐2: an intriguing association9
The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre9
Establishment of transfusion‐relevant bacteria reference strains for red blood cells9
International Forum on Policies and Practice for Transfusion of ABO and RhD Non‐Identical Platelets: Summary9
The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update9
Prediction and impact of personalized donation intervals9
Current status of rapid bacterial detection methods for platelet components: A 20‐year review by the ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria9
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men9
Impact of COVID‐19 on blood donor deferral patterns during the COVID‐19 pandemic: A retrospective analysis8
Abstract8
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID‐19: A qualitative study8
International survey of strategies to mitigate transfusion‐transmittedTrypanosoma cruzi in non‐endemic countries, 2016–20188
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)8
Abstract8
Residual risks of bacterial contamination for pathogen‐reduced platelet components8
Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID‐19 pandemic in Cameroon8
Recommendations for in vitro evaluation of blood components collected, prepared and stored in non‐DEHP medical devices8
ISBT 2022 ‐ Abstract Book8
Association of the ABO blood group with SARS‐CoV‐2 infection in a community with low infection rate8
Red blood cell alloimmunization among recipients of blood transfusion in India: A systematic review and meta‐analysis8
International Forum on the Management of Major Haemorrhage: Summary7
Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia7
Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium7
The impact of donor ferritin testing on blood availability in Canada7
Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors7
Determinants of the intention to participate in a programme of plasma donation for fractionation among men who have sex with men7
Physician autonomy and patient rights: lessons from an enforced blood transfusion and the role of patient blood management7
Deferasirox‐associated Fanconi syndrome in adult patients with transfusional iron overload7
Management of blood transfusion services in low‐resource countries7
An open‐source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing7
Determinants of intention to return to donate blood among first‐time blood donors in Ghana7
Early packed red blood cell transfusion in major trauma patients: Evaluation and comparison of different prediction scores for massive transfusion7
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey7
Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10 years' experience6
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method6
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry6
Plasma transfusion practices: A multicentre electronic audit6
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review6
Time–temperature indicators versus temperature indicators for transfusion practice: Application in the real hospital setting6
Sequence variants in the proximal promoter and +5.8‐kb site of ABO in Koreans with weak B phenotypes6
Platelet transfusion and mortality in patients with sepsis‐induced thrombocytopenia: A propensity score matching analysis6
Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men6
The impact of revised definitions for transfusion‐associated circulatory overload and transfusion‐related acute lung injury on haemovigilance reporting6
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study6
Dose‐dependent effects of red blood cell transfusion and case mix index on venous thromboembolic events in spine surgery6
A case of Philadelphia chromosome‐positive acute lymphocytic leukaemia with type I CD36 deficiency6
Blood transfusion activity in a general hospital during the COVID‐19 pandemic6
Preventing alloimmunization using a new model for matching extensively typed red blood cells6
A discrete‐event simulation model for analysing and improving operations in a blood donation centre6
Blood donor eligibility criteria for medical conditions: A BEST collaborative study6
Qualifying coronavirus disease 2019 convalescent plasma donors in Israel6
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis6
Preventing transfusion‐transmitted malaria in France6
The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers6
First annual report of Chinese haemovigilance network6
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies5
Patterns of red‐cell transfusion use in obstetric practice in Sweden 2003‐2017: A nationwide study5
An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers5
International Forum on Gender Identification and Blood Collection: Summary5
Polycythaemia vera: molecular genetics, diagnostics and therapeutics5
Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight5
Evolving the gay, bisexual and other men who have sex with men time‐based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes5
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 20225
Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variantCreutzfeldt–Jakobdisease5
Use of selective phenotyping and genotyping to identify rare blood donors in Canada5
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project5
Filariasis and transfusion‐associated risk: a literature review5
Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers5
The history of buffy coat platelet concentrates: The Dutch story5
Impacts of COVID‐19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia5
Does ABO blood group influence antibody response to SARS‐CoV‐2 vaccination?5
Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies5
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial5
Low neutralization capacity against SARS‐CoV‐2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.15
Mortality and outcomes by blood group in trauma patients: A systematic review and meta‐analysis5
High false discovery rate of the Architect anti‐HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing5
An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study5
Characterization of health issues in young first‐time blood donors5
Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men5
COVID‐19 convalescent plasma: Evolving strategies for serological screening in France5
Efficacy of therapeutic plasma exchange in severe COVID‐19 disease: A meta‐analysis5
High‐titre anti‐SARS‐CoV‐2 convalescent plasma donation after donors’ vaccination5
Clinical and in vitro evaluation of red blood cells collected and stored in a non‐DEHP plasticized bag system4
Development and evaluation of a community of practice to improve stem cell donor recruitment in Canada4
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study4
Platelet transfusion is associated with 90‐day and 1‐year mortality for adult patients requiring veno‐arterial extracorporeal membrane oxygenation4
Reduced neutralizing antibody potency of COVID‐19 convalescent vaccinated plasma against SARS‐CoV‐2 Omicron variant4
DEHT is a suitable plasticizer option for phthalate‐free storage of irradiated red blood cells4
Impact of restrictive red blood cell transfusion strategy on thrombosis‐related events: A meta‐analysis and systematic review4
Frequency and timing of all‐cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances4
Adverse events caused by cord blood infusion in Japan during a 5‐year period4
A comparison of the effect of X and gamma irradiation on red cell storage quality4
Application of unsupervised machine learning to identify areas of blood product wastage in transfusion medicine4
Implementation of amotosalen plus ultraviolet A‐mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections4
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply4
Rapid genotyping of 508G>A (rs3745635) and 1067T>A (rs3894326) of FUT3 by a duplex Eprobe‐mediated melting curve analysis4
White paper on pandemic preparedness in the blood supply4
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure4
The impact of the COVID‐19 outbreak on activation of the massive transfusion protocol in the emergency department4
Validation of a standardized donor health questionnaire across substances of human origin4
Altered strategy of prophylactic anti‐D administration in pregnancy to cover term and post‐term – a pilot study4
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries4
Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review4
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays4
Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 20204
Optimization of diagnostic strategy for non‐invasive cell‐free foetal RHD determination from maternal plasma4
Evaluation of the Sysmex XN‐31 automated analyser for blood donor malaria screening at Malawi Blood Transfusion Services4
Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility4
Use of O RhD‐negative red blood cells: A nationwide, prospective audit4
Plasma, platelet and red blood cell transfusion ratios for life‐threatening non‐traumatic haemorrhage in medical and post‐surgical patients: An observational study4
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral4
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy4
ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother4
Use of computational biology to compare the theoretical tertiary structures of the most common forms of RhCE and RhD4
Safety and protection of plasma donors: A scoping review and evidence gap map4
Detection and phenotype analysis of a novel Ael blood group allele4
Short‐term high‐dose intravenous iron reduced peri‐operative transfusion after staggered bilateral total knee arthroplasty: A retrospective cohort study4
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary4
Immediate intravenous iron administration improves anaemia recovery following total knee arthroplasty: A propensity‐matched analysis4
The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration4
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance3
Contamination of platelet concentrates with Staphylococcus aureus induces significant modulations in platelet functionality3
West Nile virus and blood transfusion safety: A European perspective3
Blood donation behaviour and attitudes towards the 12‐month deferral policy among gay and bisexual men in New Zealand3
Molecular blood group screening in Omani blood donors3
A randomized study of a best practice alert for platelet transfusions3
COVID‐19 infection and complications according to ABO blood group in the elderly: A population‐based subcohort and meta‐analysis3
A review of electronic medical records and safe transfusion practice for guideline development3
Plasma resuscitation improves and restores intestinal microcirculatory physiology following haemorrhagic shock3
Therapeutic granulocyte infusion for patients with severe neutropaenia and neutrophilic dysfunction: New Zealand experience3
Subjects with blood group O are not at lower risk to acquire SARS‐CoV‐2 infection3
Challenging the 30‐min rule for thawed plasma3
Is intravenous immunoglobulin a risk factor for necrotizing enterocolitis in neonates with haemolytic disease of the newborn? A retrospective cohort study3
Climate change: A call for action, even for Vox Sanguinis3
Comparison between tube test and automated column agglutination technology on VISION Max for anti‐A/B isoagglutinin titres: A multidimensional analysis3
An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation3
Profile of the single‐use, multiple‐pass protein A adsorber column in immunoadsorption3
The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients3
An international comparison of haemoglobin deferral prediction models for blood banking3
Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill3
Low‐dose prophylaxis and its impact on the health of haemophilia patients3
Degree of blood safety of voluntary non‐remunerated versus replacement blood donations: A multi‐centre study of the large cohort of blood donors from two provinces of Pakistan3
Ludwik Hirszfeld: A pioneer of transfusion and immunology during the world wars and beyond3
Factors affecting need for blood transfusion in paediatric patients undergoing open surgery for hip dysplasia3
In vitro quality of cold and delayed cold‐stored platelet concentrates from interim platelet units during storage for 21 days3
Utility of reticulocyte haemoglobin content and immature reticulocyte fraction in early diagnosis of latent iron deficiency in whole blood donors3
Iron supplementation: A qualitative study on the perception of blood donors, blood collection staff and donor physicians3
A novel quantitative method to evaluate the contribution of platelet products to white thrombus formation in reconstituted blood under flow conditions3
What influences decisions to donate plasma? A rapid review of the literature3
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease3
Inequality averse and compassionate blood donor: implication for interventions3
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study3
Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID‐19 in Brazil3
International Forum on Home‐Based Blood Transfusion: Summary3
Blood component ratios in children with non‐traumatic life‐threatening bleeding3
Low ferritin levels appear to be associated with worsened health in male repeat blood donors3
Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation3
Using competition for plasma donor recruitment and retention: An Australian university case study3
Weak D type 42: Antigen density and risk of alloimmunization in the province of Québec3
Non‐severe allergic transfusion reaction: A hidden cause of wastage of blood product and laboratory resources3
Does cold storage of blood before transfusion prevent the transmission of syphilis? A systematic review and meta‐analysis3
Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis3
MATRA‐A: A study on massive transfusion3
Modelling the outcomes of different red blood cell transfusion strategies for the treatment of traumatic haemorrhage in the prehospital setting in the United Kingdom3
Estimation of the latent therapeutic demand for immunoglobulin therapies in autoimmune neuropathies in the United States3
Is there an optimal trade‐off between anaemia and red blood cell transfusion in surgical critically ill patients after oncologic surgery?3
A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis3
The use of social media as a tool for patient blood management and transfusion medicine education3
Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors3
Changes in Parvovirus B19 positivity rates in plasma units for fractionation: An unexpected effect of non‐pharmaceutical interventions against COVID‐19?3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro3
A cross‐sectional study of haemolytic disease of the newborn in Uganda2
A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID‐19 pandemic2
Hepatitis E virus seropositivity in an ethnically diverse community blood donor population2
Paediatric clinical decision support: Evaluation of a best practice alert for red blood cell transfusion2
Comparison of automated versus semi‐automated whole blood processing systems: A systematic review2
Frequencies of glycophorin variants and alloantibodies against Hil and MINY antigens in Japanese2
Oral Presentations2
Mechanism evaluation for an amino acid substitution p.Y246C of B‐glycosyltransferase enzyme with Bweak phenotype2
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France2
Quality assessment of red blood cell suspensions derived from pathogen‐reduced whole blood2
Incidence and risk factors for graft failure in the modern era of cord blood transplantation2
pH is unsuitable as a quality control marker in platelet concentrates stored in platelet additive solutions2
A microfluidic analysis of thrombus formation in reconstituted whole blood samples comparing spray‐dried plasma versus fresh frozen plasma2
Biochemical and cellular markers differentiate recovered, in‐line filtered plasma, and plasma obtained by apheresis methods2
Psychological intervention in children with transfusion‐dependent β‐thalassaemia2
Migration of di(2‐ethylhexyl) phthalate, diisononylcyclohexane‐1,2‐dicarboxylate and di(2‐ethylhexyl) terephthalate from transfusion medical devices in labile blood products: A comparative study2
Management of children with glucose‐6‐phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs‐COV‐2 pandemic2
Estimation of Lewis‐negative alleles by high‐resolution melting analysis of three tag SNPs of FUT32
Lack of alloimmunization to the D antigen in D‐negative orthotopic liver transplant recipients receiving D‐positive red blood cells perioperatively2
Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population2
Transfusion management of trauma from the 2019 El Paso mass shooting incident2
Psychological ownership and identity motives in blood donation2
International Forum on Walking Blood Bank Programmes: Summary2
Compliance and attitudes of blood donors following transitioning from permanent to 12‐month deferral of men who have sex with men in Hong Kong2
Poster Abstracts2
Assessing inpatient platelet ordering practice: evaluation of computer provider order entry overrides2
A comparison between liquid group A plasma and thawed group A plasma for massive transfusion activation in trauma patients2
International Forum on Gender Identification and Blood Collection: Responses2
Passive immune basophil activation test for the identification of allergic episodes from various adverse events elicited by haematopoietic cell transplantation: A pilot study2
Association between leukoreduced red blood cell transfusions and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU study2
Unlikely influence of ABO blood group polymorphism on antibody response to COVID‐19 mRNA vaccine against SARS‐CoV‐2 spike protein2
Novel missense mutation c.797T>C (p.Met266Thr) gives rise to the rare B(A) phenotype in a Chinese family2
Neutralization capacity of convalescent plasma against SARS‐CoV‐2 omicron sublineages: Implications for donor selection2
The interaction between Glycophorin A (GPA) and Band 3 in the formation of the Wright b (Wrb) antigen2
Prevalence of iron deficiency and red blood cell transfusions in surgical patients2
Novel regulatory variant in ABO intronic RUNX1 binding site inducing A3 phenotype2
SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays2
Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn2
Haemoglobin S testing using HEA BeadChip™ technology: Lifeblood comparison with clinical diagnosis2
Impact of societal and legal context on the blood supply of African‐ancestry populations in Western countries: A review of practices and the French example2
Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal‐foetal incompatibility: A retrospective cohort study2
Practice patterns of ABO‐matching for cryoprecipitate and patient outcomes after ABO‐compatible versus incompatible cryoprecipitate2
Digital polymerase chain reaction to monitor platelet transfusions in cardiac surgery patients2
The immune potential of ex vivo stored platelets: a review2
Challenges in antibody titration for ABO‐incompatible renal transplantation2
Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID‐19 restriction in March 20202
0.047729969024658